Drug class movers & shakers advertising in professional health journals in Q1 2013
Among the top 25 drug classes advertising in professional health journals, these are some of the fastest growing categories in the first quarter of 2013 as compared to that time period in 2012.
Print Ad Drug Classes with Large Increases (Dollars): Jan. – Mar. 2013
- Biological Response Modifiers – $2 MM (+26%)
- Immunologic Agents – $972,000 (+86%)
- Anti-Platelets – $961,000 (+123%)
- UT Antispasmodics – $812,000 (+217%)
- Erythropoietin – $788,000 (+59%)
Humira is a key advertiser in the Biological Response Modifiers class and Effient is a major advertiser in the Anti-Platelets class.
The percentage changes compare Q1 2013 to Q1 2012. For more information on these ad insights or other data, let one of us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.